Pharmaceutical business group urges overhaul of drug pricing policy

The Korea Pharmaceutical Manufacturers Association has urged a new minister of Health, Welfare and Family Affairs to ameliorate the current drug pricing policy, the so-called positive list system, under which only medicines with proven efficacy and price-competitiveness will be covered by health insurance.

In its statement, the KPMA said that all of the drugs approved by the Korea Food and D...